Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma

被引：0

作者：

B Ghanim

M A Hoda

T Klikovits

M-P Winter

A Alimohammadi

M Grusch

B Dome

M Arns

P Schenk

M Jakopovic

M Samarzija

L Brcic

M Filipits

V Laszlo

W Klepetko

W Berger

B Hegedus

机构：

[1] Medical University of Vienna,Division of Thoracic Surgery, Department of Surgery

[2] Institute of Cancer Research,Department of Internal Medicine I

[3] Medical University of Vienna,Department of Thoracic Surgery

[4] National Koranyi Institute of Pulmonology,Department of Pulmonology

[5] National Institute of Oncology,Department for Respiratory Diseases Jordanovac

[6] LKH Hochegg,Department of Biological Physics

[7] University of Zagreb,undefined

[8] School of Medicine,undefined

[9] University Hospital Center,undefined

[10] University of Zagreb,undefined

[11] School of Medicine,undefined

[12] Institute of Pathology,undefined

[13] Eötvös University,undefined

[14] MTA-SE Molecular Oncology Research Group,undefined

[15] Hungarian Academy of Sciences,undefined

来源：

British Journal of Cancer | 2014年 / 110卷

关键词：

malignant pleural mesothelioma; fibrinogen; prognosis; predictive biomarker; multimodality therapy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：984 / 990

页数：6

共 50 条

[21] Circulating Endothelial Cell (CEC) as a Diagnostic and Prognostic Marker in Malignant Pleural Mesothelioma (MPM)
Yoneda, Kazue
Tanaka, Fumihiro
Kondo, Nobuyuki
Orui, Hayato
Hashimoto, Masaki
Takuwa, Teruhisa
Matsumoto, Seiji
Okumura, Yoshitomo
Tsubota, Noriaki
Sato, Ayuko
Tsujimura, Tohru
Kuribayashi, Kozo
Fukuoka, Kazuya
Nakano, Takashi
Hasegawa, Seiki
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (13) : 4229 - 4237
[22] Immunohistochemistry as Prognostic Markers for Malignant Pleural Mesothelioma
Otsuki, Taiichiro
Maehashi, Nobuko
Kataoka, Yuki
Terada, Takayuki
Kuribayashi, Kozo
Hirabayashi, Masataka
Ieki, Ryuji
Nakano, Takashi
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S505 - S505
[23] Biomarkers and prognostic factors for malignant pleural mesothelioma
Vigneri, Paolo
Martorana, Federica
Manzella, Livia
Stella, Stefania
FUTURE ONCOLOGY, 2015, 11 (24) : 29 - 33
[24] Pleural fluid findings as prognostic factors for malignant pleural mesothelioma
Gonlugur, Tanseli Efeoglu
Gonlugur, Ugur
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2008, 22 (05) : 334 - 336
[25] PROGNOSTIC FACTORS AND SURVIVAL IN MALIGNANT PLEURAL MESOTHELIOMA
VANGELDER, T
DAMHUIS, RAM
HOOGSTEDEN, HC
EUROPEAN RESPIRATORY JOURNAL, 1994, 7 (06) : 1035 - 1038
[26] Prognostic Factors in Patients with Malignant Pleural Mesothelioma
Kurchenkov, Aleksey N.
Kurchin, Vyacheslav P.
Zharkov, Vladimir V.
INTERNATIONAL JOURNAL OF BIOMEDICINE, 2015, 5 (01) : 7 - 10
[27] The homeobox gene EMX2 is a prognostic and predictive marker in malignant pleural mesothelioma
Leprieur, Etienne Giroux
Hirata, Tomomi
Mo, Minli
Chen, Zhao
Okamoto, Junichi
Clement, Genevieve
Li, Hui
Wislez, Marie
Jablons, David M.
He, Biao
LUNG CANCER, 2014, 85 (03) : 465 - 471
[28] Prognostic and predictive aspects of the tumor immune microenvironment and immune checkpoints in malignant pleural mesothelioma
Marcq, Elly
Siozopoulou, Vasiliki
De Waele, Jorrit
van Audenaerde, Jonas
Zwaenepoel, Karen
Santermans, Eva
Hens, Niel
Pauwels, Patrick
van Meerbeeck, Jan P.
Smits, Evelien L. J.
ONCOIMMUNOLOGY, 2017, 6 (01):
[29] Pleural Effusion VEGF Levels As A Prognostic Factor Of Malignant Pleural Mesothelioma
Hirayama, N.
Tabata, C.
Tabata, R.
Maeda, R.
Yasumitsu, A.
Yamada, S.
Kuribayashi, K.
Fukuoka, K.
Nakano, T.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
[30] Prognostic significance of serum and pleural mesothelin in malignant pleural mesothelioma (MPM)
Pinelli, Valentina
Sivori, Massimiliano
Canessa, Pier Aldo
Fontana, Vincenzo
Pistillo, Maria Pia
Ferro, Paola
Franceschini, Maria Cristina
Vigani, Antonella
Roncella, Silvio
Battolla, Enrico
EUROPEAN RESPIRATORY JOURNAL, 2017, 50

← 1 2 3 4 5 →